Y
Younan Xia
Researcher at The Wallace H. Coulter Department of Biomedical Engineering
Publications - 974
Citations - 192658
Younan Xia is an academic researcher from The Wallace H. Coulter Department of Biomedical Engineering. The author has contributed to research in topics: Nanocages & Catalysis. The author has an hindex of 216, co-authored 943 publications receiving 175757 citations. Previous affiliations of Younan Xia include Washington University in St. Louis & University of Texas at Dallas.
Papers
More filters
Journal ArticleDOI
Toughening of fibrous scaffolds by mobile mineral deposits.
TL;DR: The hypothesis that toughening of a fibrous scaffold arises from brittle mineral particles that crosslink the fibers, but only if the particles are free to slide relative to the fibers is supported.
Journal ArticleDOI
Effect of connective tissue growth factor delivered via porous sutures on the proliferative stage of intrasynovial tendon repair.
Stephen W. Linderman,Stephen W. Linderman,Hua Shen,Susumu Yoneda,Rohith Jayaram,Michael L. Tanes,Shelly E. Sakiyama-Elbert,Younan Xia,Stavros Thomopoulos,Richard H. Gelberman +9 more
TL;DR: Encouraging evidence is provided of sustained delivery of biologically active CTGF from porous sutures without signs of a negative inflammatory reaction, with the development of a safe and effective method for generating a positive local biological response.
Journal ArticleDOI
A silver nanocube on a gold microplate as a well-defined and highly active substrate for SERS detection
TL;DR: A new type of SERS substrate that was fabricated by depositing a Ag nanocube (AgNC) on the surface of a Au microplate (AuMP) showed high sensitivity and reproducibility and displayed very good stability.
Journal ArticleDOI
Targeted Delivery of Anti-miR-712 by VCAM1-Binding Au Nanospheres for Atherosclerosis Therapy
TL;DR: It is demonstrated that vascular cell adhesion molecule 1 (VCAM1), which is highly expressed on the surface of endothelial cells under d-flow, can serve as a marker for the targeted delivery of drug to the inflamed endothelium, and the combination of VCAM1-binding peptide and Au nanosphere could provide an effective strategy for the selective delivery of anti-athero-miRNAs or other drugs.